uremic encephalopathy | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

1,496 results for “uremic encephalopathy”

Trials

View all 1276 →

Evaluation of s100β, NSE and GFAP Levels in Renal Transplantation

80 participants · First posted Aug 1, 2019

s100β, NSE n GFAP in Living Donor Hepatectomy and Delirium

56 participants · First posted Jun 9, 2020

Roles of Uremic Toxins in Uremic Sacropenia

111 participants · First posted Feb 23, 2017

Drugs

View all 30 →

ACF-TEI

small molecule therapeutic (uremic pruritus)

program 4 (hepatic encephalopathy)

Organizations

Axcella Health

United States

Remix Therapeutics, Inc.

United States

Urmia University of Medical Sciences

Iran

News

View all 186 →

New Clinical Guidelines Standardize Kidney Replacement Therapy in ICU Patients

Rifaximin Monotherapy Superior to Lactulose in Preventing Hepatic Encephalopathy Recurrence

Hepatic Encephalopathy: Emerging Therapies and Clinical Trials Highlighted

Page 1 of 150